Category
Atomoxetine
CAS Number
1010818-96-8
Alternate CAS Number
1643684-06-3(HCl Salt)
Molecular Formula
C₁₇H₂₁NO
Molecular Weight
255.36 g/mol
Synonym

 (3R)-N-methyl-3-(4-methylphenoxy)-3-phenylpropan-1-amine;(R)-N-Methyl-3-phenyl-3-(p-tolyloxy)propan-1-amine;

Keywords
Pharmaceutical Standards
Intermediates
Impurities
Fine Chemicals
Impurities Manufacturer in India
Impurities manufacturer and Suppliers in Hyderabad india
Slide_1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Atomoxetine EP Impurity C (CAS No. 1010818-96-8; HCl Salt CAS No. 1643684-06-3) with molecular formula C₁₇H₂₁NO and molecular weight 255.36 g/mol is a high-quality pharmaceutical impurity standard and fine chemical identified as (3R)-N-methyl-3-(4-methylphenoxy)-3-phenylpropan-1-amine and (R)-N-Methyl-3-phenyl-3-(p-tolyloxy)propan-1-amine. Manasa Life Sciences offers Atomoxetine EP Impurity C for pharmaceutical standards, analytical testing, method development, quality control (QC), impurity profiling, pharmaceutical intermediates, fine chemicals, and synthesis R&D, prepared and characterized by expert scientists in accordance with applicable ICH, EMA, USP, and EP regulatory and quality guidelines. Comprehensive analytical characterization and testing support, including HPLC, LC-MS/Mass Spectrometry, NMR, IR spectroscopy, purity testing, identification, and quality-control analysis, can be provided along with COA, MSDS/SDS, GLP and GDP documentation, with safe and appropriate packaging for laboratory and pharmaceutical applications. Our expert scientific team supports reliable impurity reference standards, analytical research, synthesis R&D, regulatory documentation, and customized requirements for pharmaceutical development and quality assurance.